[go: up one dir, main page]

IT1299161B1 - COMPOSITION INCLUDING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND NADH AND / OR NADPH - Google Patents

COMPOSITION INCLUDING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND NADH AND / OR NADPH

Info

Publication number
IT1299161B1
IT1299161B1 IT98RM000238A ITRM980238A IT1299161B1 IT 1299161 B1 IT1299161 B1 IT 1299161B1 IT 98RM000238 A IT98RM000238 A IT 98RM000238A IT RM980238 A ITRM980238 A IT RM980238A IT 1299161 B1 IT1299161 B1 IT 1299161B1
Authority
IT
Italy
Prior art keywords
carnitine
alcanoyl
nadh
nadph
composition including
Prior art date
Application number
IT98RM000238A
Other languages
Italian (it)
Inventor
Per Il Credito Sporti Istituto
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of ITRM980238A0 publication Critical patent/ITRM980238A0/en
Priority to IT98RM000238A priority Critical patent/IT1299161B1/en
Priority to IL13901499A priority patent/IL139014A0/en
Priority to BR9909712-5A priority patent/BR9909712A/en
Priority to CA002328331A priority patent/CA2328331A1/en
Priority to HU0101914A priority patent/HUP0101914A3/en
Priority to PCT/IT1999/000088 priority patent/WO1999053921A1/en
Priority to CN99805644A priority patent/CN1299283A/en
Priority to EEP200000601A priority patent/EE200000601A/en
Priority to AU34428/99A priority patent/AU750645B2/en
Priority to EP99916039A priority patent/EP1071424A1/en
Priority to PL99343482A priority patent/PL343482A1/en
Priority to KR1020007011499A priority patent/KR20010042765A/en
Priority to SK1544-2000A priority patent/SK15442000A3/en
Priority to JP2000544325A priority patent/JP2002512191A/en
Priority to TR2000/02894T priority patent/TR200002894T2/en
Publication of ITRM980238A1 publication Critical patent/ITRM980238A1/en
Application granted granted Critical
Publication of IT1299161B1 publication Critical patent/IT1299161B1/en
Priority to NO20005128A priority patent/NO20005128L/en
Priority to IS5663A priority patent/IS5663A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT98RM000238A 1998-04-17 1998-04-17 COMPOSITION INCLUDING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND NADH AND / OR NADPH IT1299161B1 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
IT98RM000238A IT1299161B1 (en) 1998-04-17 1998-04-17 COMPOSITION INCLUDING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND NADH AND / OR NADPH
AU34428/99A AU750645B2 (en) 1998-04-17 1999-04-14 Composition comprising L-carnitine or an alkanoyl L-carnitine and NADH and/or NADPH
PL99343482A PL343482A1 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
CA002328331A CA2328331A1 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
HU0101914A HUP0101914A3 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
PCT/IT1999/000088 WO1999053921A1 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
CN99805644A CN1299283A (en) 1998-04-17 1999-04-14 Composition comprising L-carnitine or an alkanoyl L-carnitine and NADH and/or NADPH
EEP200000601A EE200000601A (en) 1998-04-17 1999-04-14 A composition comprising L-carnitine or alkanoyl L-carnitine and NADH and / or NADPH
IL13901499A IL139014A0 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
EP99916039A EP1071424A1 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
BR9909712-5A BR9909712A (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl-l-carnitine and nadh and / or madph
KR1020007011499A KR20010042765A (en) 1998-04-17 1999-04-14 Composition comprising L-carnitine or an alkanoyl L-carnitine and NADH and/or NADPH
SK1544-2000A SK15442000A3 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
JP2000544325A JP2002512191A (en) 1998-04-17 1999-04-14 A composition comprising L-carnitine or alkanoyl L-carnitine and NADH and / or HADPH.
TR2000/02894T TR200002894T2 (en) 1998-04-17 1999-04-14 L-Carnitine or an alkanoyl L-Carnitine and composition containing NADH and / or NADPH
NO20005128A NO20005128L (en) 1998-04-17 2000-10-12 Composition comprising L-carnitine or an alkanoyl-L-carnitine and NADH and / or NADPH
IS5663A IS5663A (en) 1998-04-17 2000-10-13 A composition comprising L-carnitine or alkanoyl L-carnitine and NADH and / or NADHP

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98RM000238A IT1299161B1 (en) 1998-04-17 1998-04-17 COMPOSITION INCLUDING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND NADH AND / OR NADPH

Publications (3)

Publication Number Publication Date
ITRM980238A0 ITRM980238A0 (en) 1998-04-17
ITRM980238A1 ITRM980238A1 (en) 1999-10-17
IT1299161B1 true IT1299161B1 (en) 2000-02-29

Family

ID=11405812

Family Applications (1)

Application Number Title Priority Date Filing Date
IT98RM000238A IT1299161B1 (en) 1998-04-17 1998-04-17 COMPOSITION INCLUDING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND NADH AND / OR NADPH

Country Status (17)

Country Link
EP (1) EP1071424A1 (en)
JP (1) JP2002512191A (en)
KR (1) KR20010042765A (en)
CN (1) CN1299283A (en)
AU (1) AU750645B2 (en)
BR (1) BR9909712A (en)
CA (1) CA2328331A1 (en)
EE (1) EE200000601A (en)
HU (1) HUP0101914A3 (en)
IL (1) IL139014A0 (en)
IS (1) IS5663A (en)
IT (1) IT1299161B1 (en)
NO (1) NO20005128L (en)
PL (1) PL343482A1 (en)
SK (1) SK15442000A3 (en)
TR (1) TR200002894T2 (en)
WO (1) WO1999053921A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252309B2 (en) 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
DE10326822A1 (en) * 2003-06-11 2005-01-05 Herzpharma Vita-Check Diagnosegeräte GmbH Dietary supplement, e.g. for increasing general performance, concentration and endurance, comprises NADH, L-carnitine, coenzyme Q10, L-carnosine, succinic acid, ascorbic acid and bioflavonoids
MX2009012042A (en) * 2007-05-11 2009-12-01 Sigma Tau Ind Farmaceuti Gel useful for the delivery of cosmetic active ingredients.
AU2010286348A1 (en) * 2009-08-31 2012-03-22 University Of South Australia Methods for diagnosis and treatment of chronic fatigue syndrome
CN104306390A (en) * 2014-10-23 2015-01-28 苏州人本药业有限公司 Application of reduced coenzyme II
CN104840479A (en) * 2015-02-17 2015-08-19 苏州人本药业有限公司 Application of NADPH in preparation of drugs used for treating heart diseases
ES2786774B2 (en) * 2017-12-22 2022-03-04 Bontac Bio Eng Shenzhen Co Ltd Composition for NADH coenzyme compound, preparation and application thereof.
DK3755160T3 (en) 2018-04-20 2021-12-06 Pacotrade Ag Device for comminuting deep-frozen foods in block form
CN109105702A (en) * 2018-08-30 2019-01-01 泓博元生命科技(深圳)有限公司 A kind of preparation method of composition containing NADH, application and energy extender
CN109170907A (en) * 2018-08-30 2019-01-11 泓博元生命科技(深圳)有限公司 A kind of preparation method of composition containing NMN, application and sports drink
AU2019357838A1 (en) * 2018-10-10 2021-04-15 So Ngor Sally LEUNG Health product composition for supplementing deficiency, preparation method therefor and application thereof
CN117958433A (en) * 2024-03-22 2024-05-03 四川新渔新美健康科技有限公司 Caffeine-free anti-fatigue functional composition and beverage

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054698A (en) * 1964-12-04
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
DE4335454A1 (en) * 1993-10-19 1995-04-20 Schleicher Peter Geriatric medical composition
JPH09110708A (en) * 1995-08-11 1997-04-28 Taisho Pharmaceut Co Ltd Nutritional tonic crude drug combination preparation
JPH0959161A (en) * 1995-08-23 1997-03-04 Taisho Pharmaceut Co Ltd Fatigue improving composition
IT1277953B1 (en) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITION CONTAINING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND A 3-OMEGA SERIES POLYUNSATURED ACID USEFUL
IT1283951B1 (en) * 1996-03-15 1998-05-07 Mendes Srl USE OF ACETYL L-CARNITINE OR ITS PHARMACOLOGICALLY ACCEPTABLE SALTS FOR THERAPEUTIC TREATMENT OR PROPHYLAXIS OF
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
JPH10175856A (en) * 1996-10-14 1998-06-30 Taisho Pharmaceut Co Ltd Fatigue improver

Also Published As

Publication number Publication date
SK15442000A3 (en) 2001-06-11
NO20005128L (en) 2000-12-18
NO20005128D0 (en) 2000-10-12
CN1299283A (en) 2001-06-13
EE200000601A (en) 2002-04-15
BR9909712A (en) 2000-12-26
WO1999053921A1 (en) 1999-10-28
AU750645B2 (en) 2002-07-25
JP2002512191A (en) 2002-04-23
HUP0101914A2 (en) 2002-03-28
KR20010042765A (en) 2001-05-25
PL343482A1 (en) 2001-08-27
IS5663A (en) 2000-10-13
AU3442899A (en) 1999-11-08
ITRM980238A1 (en) 1999-10-17
CA2328331A1 (en) 1999-10-28
HUP0101914A3 (en) 2002-12-28
EP1071424A1 (en) 2001-01-31
ITRM980238A0 (en) 1998-04-17
IL139014A0 (en) 2001-11-25
TR200002894T2 (en) 2001-01-22

Similar Documents

Publication Publication Date Title
IL183948A0 (en) Conjugates of peg-urate oxidase and use thereof
HUP0104270A3 (en) Herbicidal composition and use thereof
DE69927945D1 (en) ELECTROMECHANIC PROTECTION
DK1112003T3 (en) New composition and application
DE69933544D1 (en) POLYMER AND HARDENABLE COMPOSITION
DE69909919D1 (en) Water dispersible water and oil repellent composition
NO20006488D0 (en) Composition and application
PT1139761E (en) HERBICID AND CONCENTRATED COMPOSITIONS
DE69836248D1 (en) Water and oil repellent composition
IL136534A0 (en) Magnetic bearing and its use
SG87813A1 (en) Curable epoxide composition and its use
IT1299161B1 (en) COMPOSITION INCLUDING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND NADH AND / OR NADPH
DE69917327D1 (en) 3,3-BIARYLPIPERIDIN AND 3,3-BIARYLMORPHOLINE DERIVATIVES
NO993694D0 (en) Sylphonylurea and adjuvant based solid compositions
DE69822091D1 (en) Photosensitive polymer and chemically amplified resist composition containing the same
GB9803232D0 (en) Compound composition and use
PT811593E (en) INSECTICID AND ACARICID AGENTS 1,4-DIARY-2-FLUOR-2-BUTENE
DE69926160D1 (en) Toner composition and its preparation
ITMI980827A1 (en) COMPOSITIONS AND SUBSTANCES WITH DERMOPROLIFERATIVE ACTIVITY
SE9900878D0 (en) New composition and use thereof
GB9805172D0 (en) Composition and use
UA2190S (en) SET OF LABELS "ANCIENT KIIVSKA"
UA2780S (en) SET OF LABELS "ANCIENT KYIVSKE"
FI974109A0 (en) Arrangements and arrangements
BR9602062A (en) Lottery collector and processor - tl 2000

Legal Events

Date Code Title Description
0001 Granted